U.S. regulators have approved a new drug for hepatitis B, bepirovirsen, which can help patients suppress the virus in just six months of treatment, providing hope for an end to daily antiviral pill intake, although it does not work for all patients and causes serious side effects. #hepatitisB #noviLijek #zdravlje (translated)
dnevnik.hr
Kraj svakodnevnih tableta? Odobren novi lijek za hepatitis B koji djeluje u samo šest mjeseci
